OKT With Gaze and Postural Stabilization on Vertigo, MS and QOL in VBH
4. maj 2026 opdateret af: Riphah International University
Effects of Optokinetic Training With Gaze and Postural Stabilization on Vertigo, Motion Sickness and Quality of Life in Vestibular Hypofunction
The objective of this study will evaluate the effects of optokinetic training combined with postural stabilization and gaze stability exercises on motion sickness, balance, gaze stability, and quality of life in individuals with vestibular hypofunction.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
A randomized clinical trial will be conducted with 32 participants assigned to two groups: Group A (breathing and aerobic exercises) and Group B (optokinetic training combined with postural stabilization and gaze stability exercises).
Data will be collected using the Motion Sickness Susceptibility Questionnaire (MSSQ), Berg Balance Scale (BBS), Dynamic Visual Acuity Test for Gaze Stability, and Head Impulse Test.
Statistical analysis will be performed by SPSS.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
32
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Muneeb Khan, PhD
- Telefonnummer: 923367993611
- E-mail: muneeb.khan@riphah.edu.pk
Studiesteder
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54500
- Ittefaq Hospital Lahore
-
Kontakt:
- Javeria Ghazal, MSNMPT
- Telefonnummer: +923335154664
- E-mail: javeria.ghazal@riphah.edu.pk
-
Ledende efterforsker:
- Asad Shahzad Mir, MsNMPT
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
• Male and female patients age 20 and 40 years
- Passengers who have motion sickness during travelling
- Patients of vestibular migraine who experience motion sickness
- Participants experiencing vertigo, dizziness or imbalance related to vestibular hypofunction over the past three months
Exclusion Criteria:
• Patients who have seasickness and simulator sickness excluded.
- Patients having vestibular disease and chronic neurological disease.
- Participants who have completed formal vestibular rehabilitation in last 6 months excluded
- Patients with severe visual impairments and orthopedic conditions excluded.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Group A Habituation exercises
Group A performed a regime of Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness
|
Habituation exercises five times per week to improve overall wellness and reduce baseline symptoms of motion sickness (38).
Each session, lasting approximately 20-25 minutes, involved exercises conducted for 20 minutes per day, five times a week.
Each session, lasting approximately 30-45 minutes, included low-intensity breathing exercises aimed at promoting relaxation and moderate-intensity aerobic activities, such as walking or cycling, at 50-60% of the participant's maximum heart rate.
|
|
Eksperimentel: Group B Optokinetic training protocol
Group B underwent a structured optokinetic training protocol combined with postural stabilization and gaze stability exercises, targeting both gaze and postural control systems.
|
10-minute warm-up, followed by 20-25 minutes of moderate-intensity optokinetic exercises (viewing controlled moving visual patterns), postural exercises involving controlled head and body movements to engage the vestibular system, and gaze stability exercises, which require focusing on a stationary target during head movements to improve the vestibulo-ocular reflex.
The session concluded with a 10-15-minute cool-down to aid relaxation.
These sessions continued for 12 weeks
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Motion sickness susceptibility questionnaire
Tidsramme: 8th week
|
The Motion Sickness Susceptibility Questionnaire (MSSQ) is a widely used tool that assesses an individual's predisposition to motion sickness in various environments, such as vehicles, amusement rides, and virtual reality.
|
8th week
|
|
Berg balance scale
Tidsramme: 8th week
|
The Berg Balance Scale (BBS) is a reliable clinical tool used to assess balance in individuals, particularly older adults and those with balance impairments.
It includes 14 tasks each scored from 0 (cannot perform) to 4 (performs independently).
The BBS has a maximum score of 56, and most of the patients show a low fall risk of 41 to 56 scores, medium risk of 21 to 40 scores, and a high risk of 0 to 20 scores.
|
8th week
|
|
Dynamic visual acuity test for gaze stability
Tidsramme: 8th week
|
The Dynamic Visual Acuity (DVA) Test is a widely used clinical test to assess gaze stability, particularly in individuals with vestibular dysfunction.
It evaluates a person's ability to maintain clear vision during head movements, which requires stable gaze control.
The test involves reading porotype letters or symbols displayed on a screen, first in a stationary position and then while moving the head horizontally and vertically at a standardized speed (usually around 2 Hz)
|
8th week
|
|
Head impulse test
Tidsramme: 8th week
|
The Head Impulse Test (HIT) is a diagnostic tool used to evaluate the function of the vestibulo-ocular reflex (VOR), essential for maintaining gaze stability during rapid head movements.
In this test, a clinician rapidly and unpredictably turns the patient's head to the left or right while the patient focuses on a stationary target, typically the clinician's nose.
For a healthy VOR, the eyes should remain fixed on the target despite the head movement
|
8th week
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Javeria Ghazal, MSNMPT, Riphah International University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
15. maj 2026
Primær færdiggørelse (Anslået)
15. august 2026
Studieafslutning (Anslået)
14. september 2026
Datoer for studieregistrering
Først indsendt
22. februar 2026
Først indsendt, der opfyldte QC-kriterier
4. maj 2026
Først opslået (Faktiske)
8. maj 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
8. maj 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
4. maj 2026
Sidst verificeret
1. maj 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- REC/RCR & AHS/24/02100
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .